{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:04:11Z","timestamp":1791947051659,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1111\/1469-0691.12688","type":"journal-article","created":{"date-parts":[[2014,5,26]],"date-time":"2014-05-26T15:08:38Z","timestamp":1401116918000},"page":"O952-O959","source":"Crossref","is-referenced-by-count":102,"title":["Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study"],"prefix":"10.1016","volume":"20","author":[{"given":"N.","family":"Lerolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Raffoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Socie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Touratier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sauvageon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Porcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bretagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lafaurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12688_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00277-011-1373-2","article-title":"A prospective survey of febrile events in hematological malignancies","volume":"91","author":"Pagano","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1111\/1469-0691.12688_bib2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant\u2010Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12688_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.blre.2008.10.003","article-title":"Bloodstream infections in haematology: risks and new challenges for prevention","volume":"23","author":"Worth","year":"2009","journal-title":"Blood Rev"},{"key":"10.1111\/1469-0691.12688_bib4","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12688_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12688_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/dkp507","article-title":"Overall survival and fungal infection\u2010related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006","volume":"65","author":"Hahn\u2010Ast","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12688_bib7","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis\u2010related death in allogeneic marrow transplant recipients: long\u2010term follow\u2010up of a randomized, placebo\u2010controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1111\/1469-0691.12688_bib8","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"10.1111\/1469-0691.12688_bib9","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: the RetroZygo Study (2005\u20132007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12688_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12688_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft\u2010versus\u2010host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12688_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(05)70297-8","article-title":"Posaconazole: a broad\u2010spectrum triazole antifungal","volume":"5","author":"Torres","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12688_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1439-0507.2010.01984.x","article-title":"Posaconazole: clinical pharmacokinetics and drug interactions","volume":"54","author":"Lipp","year":"2011","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12688_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijantimicag.2012.02.002","article-title":"Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies","volume":"39","author":"Hoenigl","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/1469-0691.12688_bib15","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1128\/AAC.05900-11","article-title":"Posaconazole exposure\u2010response relationship: evaluating the utility of therapeutic drug monitoring","volume":"56","author":"Dolton","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12688_bib16","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/jac\/dks189","article-title":"Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high\u2010risk patients receiving antifungal prophylaxis with posaconazole: real\u2010life data from a single\u2010centre institutional retrospective observational study","volume":"67","author":"Auberger","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12688_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jinf.2012.11.009","article-title":"Real\u2010world experience with posaconazole prophylaxis in high\u2010risk hematological patients in Singapore: a prospective audit","volume":"66","author":"Low","year":"2013","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12688_bib18","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/jac\/dkq121","article-title":"Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6\u00a0year experience of the Cologne AML cohort","volume":"65","author":"Vehreschild","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12688_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1439-0507.2010.01980.x","article-title":"Clinical experience with posaconazole prophylaxis\u2013a retrospective analysis in a haematological unit","volume":"54","author":"Hahn","year":"2011","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12688_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbmt.2010.04.017","article-title":"Efficacy, safety, and breakthrough infections associated with standard long\u2010term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients","volume":"17","author":"Winston","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/1469-0691.12688_bib21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12688_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing (AFST)","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12688_bib23","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/AAC.47.7.2348-2350.2003","article-title":"Development and validation of a high\u2010performance liquid chromatography assay for voriconazole","volume":"47","author":"Pennick","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12688_bib24","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/cis773","article-title":"Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010\u2010B registry","volume":"55","author":"Pagano","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12688_bib25","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1128\/AAC.00939-09","article-title":"Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults","volume":"53","author":"Lebeaux","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12688_bib26","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1128\/AAC.00815-12","article-title":"Therapeutic drug monitoring of posaconazole in allogeneic hematopoietic stem cell transplantation patients who develop gastrointestinal graft\u2010versus\u2010host disease","volume":"56","author":"Tonini","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12688_bib27","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1128\/AAC.01177-12","article-title":"Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplastic syndrome","volume":"56","author":"Vaes","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12688_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QCO.0b013e328359a56e","article-title":"Making sense of posaconazole therapeutic drug monitoring: a practical approach","volume":"25","author":"Ananda\u2010Rajah","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/1469-0691.12688_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/AAC.00663-08","article-title":"Intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole at steady state in healthy subjects","volume":"53","author":"Conte","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12688_bib30","first-page":"681","article-title":"Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole","volume":"49","author":"Michallet","year":"2011","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12688_bib31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QCO.0b013e32834ab1f4","article-title":"Genetic variants and the risk for invasive mould disease in immunocompromised hematology patients","volume":"24","author":"Van der Velden","year":"2011","journal-title":"Curr Opin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14653532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14653532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T04:14:19Z","timestamp":1597896859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14653532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1198743X14653532"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12688","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}